🇺🇸 FDA
Pipeline program

Indibulin

IBL2001

Phase 2 small_molecule active

Quick answer

Indibulin for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Alaunos Therapeutics
Indication
Metastatic Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials